The first line of your post says " the cohort 3 data observed so far must be positive".
I thought what was announced today in the PR was a reflection of what IPIX has for data now and that is the final (topline) results. I must be mistaken because I have seen others saying final results later this year.
Am I correct in thinking B-OM and B-UP/UPS trials are over and what we have now (and obviously the BP's w/ CDA's have now) is the data that they will be using in determining a partnership/deal?
Looking for clarification. Thx.
I thought what was announced today in the PR was a reflection of what IPIX has for data now and that is the final (topline) results. I must be mistaken because I have seen others saying final results later this year.
Am I correct in thinking B-OM and B-UP/UPS trials are over and what we have now (and obviously the BP's w/ CDA's have now) is the data that they will be using in determining a partnership/deal?
Looking for clarification. Thx.